Constantinos Sioutas Selected Research

Particulate Matter

1/2021	Air Pollution Particulate Matter Amplifies White Matter Vascular Pathology and Demyelination Caused by Hypoperfusion.
1/2021	Air Pollution Particulate Matter Exposure and Chronic Cerebral Hypoperfusion and Measures of White Matter Injury in a Murine Model.
1/2021	Association of systemic inflammation and coagulation biomarkers with source-specific PM2.5 mass concentrations among young and elderly subjects in central Tehran.
1/2021	Nanoparticulate matter exposure results in white matter damage and an inflammatory microglial response in an experimental murine model.
1/2021	Alterations to the urinary metabolome following semi-controlled short exposures to ultrafine particles at a major airport.
11/2020	A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma.
10/2020	Effects of ambient particulate matter on vascular tissue: a review.
12/2019	Exposure to Nanoscale Particulate Matter from Gestation to Adulthood Impairs Metabolic Homeostasis in Mice.
12/2019	Cell-based assays that predict in vivo neurotoxicity of urban ambient nano-sized particulate matter.
10/2018	A Jagged 1-Notch 4 molecular switch mediates airway inflammation induced by ultrafine particles.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Constantinos Sioutas Research Topics

Disease

30	Inflammation (Inflammations) 01/2021 - 06/2004
10	Asthma (Bronchial Asthma) 11/2022 - 09/2004
10	Atherosclerosis 01/2018 - 08/2005
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 01/2006
4	Pneumonia (Pneumonitis) 11/2022 - 05/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 02/2011 - 07/2008
2	Neuroinflammatory Diseases 01/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2018
2	Obesity 12/2019 - 05/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 10/2004
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016 - 01/2015
2	Myocardial Infarction 05/2010 - 08/2005
1	COVID-19 03/2021
1	Dementia (Dementias) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2021
1	Insulin Resistance 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 12/2019
1	Cognitive Dysfunction 12/2019
1	Neoplasms (Cancer) 11/2018
1	Stillbirth 01/2018
1	Birth Weight (Birth Weights) 12/2017
1	Hypercholesterolemia 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Atrophy 01/2017
1	Stroke (Strokes) 01/2016
1	Ischemic Stroke 01/2016
1	Heart Diseases (Heart Disease) 11/2015
1	Cystic Fibrosis (Mucoviscidosis) 06/2015
1	Lung Diseases (Lung Disease) 06/2015
1	Ventricular Tachycardia 10/2013
1	Cardiac Arrhythmias (Arrythmia) 10/2013
1	Vascular Calcification 02/2013
1	Burns 01/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2011
1	Ischemia 02/2011
1	Hypersensitivity (Allergy) 09/2005

Drug/Important Bio-Agent (IBA)

44	Particulate MatterIBA 01/2021 - 10/2004
11	Environmental Pollutants (Pollutants, Environmental)IBA 11/2022 - 09/2004
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2005
10	Air Pollutants (Pollutants, Air)IBA 01/2021 - 04/2008
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 08/2006
6	Vehicle Emissions (Emissions, Vehicle)IBA 11/2018 - 01/2007
6	CytokinesIBA 01/2017 - 09/2010
5	AllergensIBA 11/2022 - 02/2010
5	AntioxidantsIBA 01/2020 - 07/2008
4	AerosolsIBA 01/2018 - 07/2008
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016 - 06/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2015 - 08/2005
4	EnzymesIBA 01/2013 - 09/2004
3	Nitrogen DioxideIBA 03/2021 - 03/2005
3	C-Reactive ProteinIBA 01/2021 - 08/2009
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 11/2022 - 08/2015
2	Biological ProductsIBA 01/2021 - 05/2005
2	Peptides (Polypeptides)IBA 01/2019 - 01/2015
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2018 - 08/2015
2	Apolipoproteins E (ApoE)IBA 11/2015 - 08/2009
2	Immunoglobulin E (IgE)IBA 08/2015 - 09/2005
2	LipidsIBA 06/2013 - 01/2007
2	Organic Chemicals (Chemicals, Organic)IBA 06/2010 - 01/2007
2	Fossil Fuels (Fossil Fuel)IBA 05/2010 - 11/2006
2	Proteins (Proteins, Gene)FDA Link 02/2010 - 05/2005
1	beta CateninIBA 11/2022
1	Benzene (Benzole)IBA 03/2021
1	von Willebrand FactorIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2020
1	Notch4 ReceptorIBA 11/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2020
1	pyreneIBA 11/2018
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 11/2018
1	Jagged-1 ProteinIBA 10/2018
1	LysophospholipidsIBA 01/2017
1	Cholestanol (Coprostanol)IBA 01/2017
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2017
1	oxidized low density lipoproteinIBA 10/2016
1	Malondialdehyde (Propanedial)IBA 10/2016
1	Sulfates (Sulfates, Inorganic)IBA 01/2016
1	NitratesIBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2015
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2015
1	CarbonIBA 10/2013
1	OzoneIBA 10/2013
1	LDL Receptors (LDL Receptor)IBA 02/2013
1	Fuel Oils (Fuel Oil)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	GasesIBA 02/2011
1	SelectinsIBA 08/2009
1	OvalbuminIBA 07/2009
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2007
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2007
1	Oxidants (Oxidizing Agents)IBA 08/2006
1	Interleukin-13IBA 09/2005
1	InterleukinsIBA 09/2005
1	Immunoglobulins (Immunoglobulin)IBA 09/2005

Therapy/Procedure

1	Therapeutics 11/2020
1	Nanospheres 08/2006